Simulated Markets vs Real Participants: How Much Evidence Does the Decision Need?
A simulated-market experiment can carry an exploratory decision when its calibration is relevant and the cost of a wrong call is limited. It should not carry every decision alone. Pricing commitments, major launches, regulated-market choices, and emotionally sensitive questions can justify testing the same causal question with real participants before the organization commits.
Trust should rise with consequence
A low-cost concept screen can use a simulated experiment to reject weak options or identify a direction worth studying. A choice that commits budget, changes price, or affects a regulated population needs a stronger basis.
| Decision situation | What a simulated-market experiment can support | When real-participant evidence becomes important |
|---|---|---|
| Early concept screening | Reject clearly weak ideas and identify promising directions | When the chosen direction will immediately trigger a material commitment |
| Comparative ranking across 5 concepts | A historical planning example for narrowing the field under one consistent study design | When small differences between finalists would change the decision |
| Messaging or positioning exploration | Test causal contrasts and expose likely objections | When emotional nuance or cultural context is central to the choice |
| Final pricing or launch commitment | Generate a hypothesis and a directional result | Before committing material budget, roadmap capacity, or market exposure |
| Regulated, legal, or emotionally sensitive choice | Help define the question and competing scenarios | Before treating the result as decision evidence |
| New market with thin calibration data | Reveal assumptions that require examination | Before generalizing to the target population |
The 5-concept row is an inherited historical planning example, not a current Subconscious limit or recommendation, and the table itself is a decision framework rather than a claim that one method is sufficient for every study in a row.
Calibration is the hinge
Calibration determines how much weight a simulated result deserves. A result checked against known human outcomes carries different evidence from an untested population description. Relevance matters too: evidence from one corpus does not automatically transfer to a new market, question type, or decision.
Our best configuration reaches 87% of the measured human ceiling on one study: 0.832 rank correlation against the published human result, where two independent samples of real humans reach 0.959. Across all 43 studies that pass design filters the mean is 0.73. The validation corpus covers roughly 300 replicated studies across 9 domains. The causal fidelity paper describes that evidence.
That result is a validation finding for a specific published-study corpus. It is not a guarantee for every market, segment, question, or commercial outcome.
What the wider research record adds
Research on language-model-assisted choice modelling reports sensitivity to prompting strategies and difficulty representing heterogeneity across people. The choice-modelling paper examines those limits.
A separate Nature paper presents a foundation model for predicting and capturing human cognition. Neither paper establishes the performance of a particular commercial study. Together, they make a narrower point useful to buyers: population-level pattern reproduction and individual-level fidelity are different standards of evidence.
Where simulation should yield to human validation
Real-participant confirmation matters when:
- the market has thin or irrelevant calibration data;
- legal, regulatory, clinical, or emotional context could change behavior;
- segment heterogeneity is central to the decision;
- the study design does not support the confidence intervals, segment comparisons, or rankings the buyer wants to use;
- the downside could threaten the product, brand, or business.
An inherited hundred-million-dollar launch scenario is best treated as a historical planning example: the scale illustrates why evidence requirements should increase with exposure, not a benchmark for when human confirmation begins.
Subconscious can test or validate studies with real human participants. A team can therefore move from a simulated-market experiment to human validation without changing the underlying causal question. That continuity helps isolate whether the evidence, rather than a newly framed question, changed the conclusion.
This does not turn a causal action test into an observed usability session, clinical trial, or automatic proof of market performance, and it does not make confidence intervals, segment breakdowns, or scenario rankings universal outputs; those depend on the specific study design.
Design the study around the commitment
Start by naming the action the evidence will authorize and the consequence if the direction is wrong. Then choose a causal experiment that preserves that question across simulation and real-human validation. Review case studies for examples of decision-focused research, or discuss the decision before fixing the study design.